ArticleTrials2022

Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone.

John Marsden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.